Please provide your email address to receive an email when new articles are posted on . The first proposed definition for disease modification in systemic lupus erythematosus, including lupus ...

Government and other scientists are proposing a new way to define Alzheimer's disease — basing it on biological signs, such as brain changes, rather than memory loss and other symptoms of dementia ...

Lewy body diseases -- Parkinson's disease and dementia with Lewy bodies -- should be defined as neuronal alpha-synuclein disease, not as clinical syndromes, a new position paper proposed. "Parkinson's ...

The World Health Organization and 500 experts have established a consensus on the definition of airborne diseases. The groups are aiming to prevent confusion similar to that experienced during the ...

Just as fluid biomarkers for amyloidosis and tau have revolutionized clinical studies of Alzheimer’s disease, α-synuclein markers are poised to do the same for Parkinson’s. With the advent of ...

Alzheimer’s disease (AD) is a progressive, neurodegenerative disease characterized by accumulation of beta-amyloid in extracellular plaques and tau protein in intracellular neurofibrillary tangles ...

Several dozen studies focused on oligometastatic disease (OMD) were presented across four major oncology meetings of 2025, underscoring that what was once a speculative concept is now a cornerstone of ...